In charge of operational management of pricing, commercial discounts, and allowances for the Gross to Net across 25+ countries, with a focus on optimizing the efficiency of the commercial team.- Received and reduced Credit Memos Accruals by USD 2.6MM, decreasing by over 60% in less than 5 months and settling commercial debts for 2022 and 2023.- Minimized errors in billing, inventory, and demand planning through the pre-merger update of the price list with Allergan Aesthetics.- Initiated and managed a credit note tracking file with key stakeholders, consolidating all 2023 credit notes. This approach significantly enhanced the management of discounts and agreements, ultimately raising customer satisfaction.

In charge of consolidating Financial Statements (PLAN, LRP, LBE, ADS) and developing the short and long-term Financial Plan for 2022, 2023, and 2024, ensuring its proper functioning and management. Responsible for monitoring administrative and medical expenses for +25 countries.- Led the integration of Allergan Aesthetics' P&L into AbbVie's local systems, enabling analysis and visualization of this business segment, previously non-existent before the merger.- Redefined the demand forecasting loading methodology for production, reducing system loading time by 90% and eliminating errors.- Enhanced inventory management efficiency through effective alignment between business needs and SKU product availability.

- Led the implementation of the automated Credit Memos settlement program, eliminating errors in their creation by 100%.- Increased the operating margin of the 2021 P&L by USD 50K through the restructuring of cost closing methodology in the region.